Insights into testosterone recovery after androgen deprivation therapy for prostate cancer

A study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center sheds light on testosterone recovery following androgen deprivation therapy (ADT) in men undergoing radiotherapy for prostate cancer, providing key insights for optimizing patient care.

Baltimore claims Biogen ‘bribed’ PBMs to favor its pricey MS drug over generics

In the latest slap at a pharmaceutical company by a local government, the city of Baltimore has filed a lawsuit accusing Biogen of striking an

September 24, 2024

Vertex secures CHMP nod for Casgevy approval in Europe – Pharmaceutical Technology

Share this article Casgevy became first FDA-approved medicine to use CRISPR/Cas9 gene-editing technology. Image credit: Shutterstock/Nemes Laszlo. Vertex Pharmaceuticals has gained a positive opinion from

December 18, 2023

2024 CHIME Digital Health Most Wired Survey: Governance and Automation Shape Healthcare IT

What You Should Know: The College of Healthcare Information Management Executives (CHIME) has released its annual Digital Health Most Wired (DHMW) survey report, providing valuable

November 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.